The Use of the Protease Inhibitor, Saquinavir, to Treat Anal Cancer Spheroids Derived From Human Papillomavirus Transgenic Mice.

Johnson HR, Gunder LC, Leverson GE, Carchman EH

Open source

DOI
10.1097/dcr.0000000000002623
Published
2023 Mar 1
Container
Diseases of the colon and rectum
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/dcr.0000000000002623,
  title = {The Use of the Protease Inhibitor, Saquinavir, to Treat Anal Cancer Spheroids Derived From Human Papillomavirus Transgenic Mice.},
  author = {Johnson HR and Gunder LC and Leverson GE and Carchman EH},
  year = {2023},
  journal = {Diseases of the colon and rectum},
  doi = {10.1097/dcr.0000000000002623},
  url = {https://doi.org/10.1097/dcr.0000000000002623}
}

RIS

TY  - JOUR
TI  - The Use of the Protease Inhibitor, Saquinavir, to Treat Anal Cancer Spheroids Derived From Human Papillomavirus Transgenic Mice.
AU  - Johnson HR
AU  - Gunder LC
AU  - Leverson GE
AU  - Carchman EH
PY  - 2023
JO  - Diseases of the colon and rectum
DO  - 10.1097/dcr.0000000000002623
UR  - https://doi.org/10.1097/dcr.0000000000002623
ER  - 

APA

HR, J., LC, G., GE, L., & EH, C. (2023). The Use of the Protease Inhibitor, Saquinavir, to Treat Anal Cancer Spheroids Derived From Human Papillomavirus Transgenic Mice.. Diseases of the colon and rectum. https://doi.org/10.1097/dcr.0000000000002623

Source records